Karin Helena Johansson Wingstrand
Director/Board Member bei INTEGRUM AB
Ursprung des Netzwerks ersten Grades von Karin Helena Johansson Wingstrand
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden.
41
| Private Company | Investment Managers | 41 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
27
| Subsidiary | Miscellaneous Commercial Services | 27 |
21
| Public Company | Medical Specialties | 21 |
| Public Company | Pharmaceuticals: Major | 20 | |
11
| Public Company | Biotechnology | 11 |
T-Bolaget AB
 T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden.
2
| Private Company | Financial Conglomerates | 2 |
Histolab Products AB
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Karin Helena Johansson Wingstrand
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor Compliance Officer Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member General Counsel | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel Director/Board Member | |
| GLYCOREX TRANSPLANTATION AB | Medical Specialties | President Director/Board Member | |
| RECIPHARM AB (PUBL) | Biotechnology | Founder Director/Board Member Corporate Officer/Principal General Counsel | |
| Karolinska Institutet | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Pharmacia AB /Hillerod Unit/
 Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| OREXO AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| ATTANA AB | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Director/Board Member Doctorate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Faculty of Engineering, Lund University | College/University | Doctorate Degree Graduate Degree | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Director/Board Member Chief Executive Officer | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Mölnlycke Health Care AB
 Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| LIDDS AB | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Director/Board Member Chairman Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member Founder Founder Chief Executive Officer | |
| ACUCORT AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman | |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| MONIVENT AB | Medical Specialties | Director/Board Member Director/Board Member Chief Executive Officer | |
| Pulsetten AB | Director/Board Member Chief Executive Officer Director/Board Member | ||
| ADDLIFE AB | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer | |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Chairman Founder Director/Board Member Director/Board Member Director/Board Member | |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Packaged Software | Director/Board Member Chairman | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
| Immodulate Pharma AB | Director/Board Member Director/Board Member Chief Executive Officer | ||
Puls AB
 Puls AB Environmental ServicesIndustrial Services Puls AB is a private company based in southern Sweden that specializes in sewage, industrial, and environmental services. The Swedish company's on-call services include emergency stops in the drain, sewage cleaning, and wastewater flushing. The company also uses water blasting as an environmentally friendly method to clean tanks, cisterns, sheet metal, and boat hulls. Puls is the largest player in VA maintenance in southern Sweden and has a team of talented employees who specialize in water and wastewater in tenant-owner associations. The company offers preventive maintenance work and emergency measures to help associations with their maintenance needs. | Environmental Services | Chief Executive Officer Corporate Officer/Principal | |
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chairman |
Statistik
International
| Schweden | 49 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Health Services | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 456 |
| Corporate Officer/Principal | 155 |
| Chairman | 130 |
| Chief Executive Officer | 87 |
| Independent Dir/Board Member | 79 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Karin Helena Johansson Wingstrand
- Unternehmensverbindungen
